Lukas Scheibler's Net Worth
$5.9 Million
Who is Lukas Scheibler?
Lukas Scheibler has an estimated net worth of $5.9 Million. This is based on reported shares across multiple companies, which include ACUCELA INC., and Apellis Pharmaceuticals, Inc..
SEC CIK
Lukas Scheibler's CIK is 0001651281
Past Insider Trading and Trends
2017 was Lukas Scheibler's most active year for acquiring shares with 9 total transactions. Lukas Scheibler's most active month to acquire stocks was the month of December. 2022 was Lukas Scheibler's most active year for disposing of shares, totalling 21 transactions. Lukas Scheibler's most active month to dispose stocks was the month of March. 2023 saw Lukas Scheibler paying a total of $2,006,455.52 for 91,961 shares, this is the most they've acquired in one year. In 2022 Lukas Scheibler cashed out on 102,303 shares for a total of $2,431,161.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACUCELA INC. No price found
EVP Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.57% | 1.41K |
$6.50 | -$8,125.00 | 11.11K |
Jul 17
| |||
Form 4
| +16.37% | 1.36K |
$6.95 | -$9,035.00 | 9.7K |
Jun 17 - Jun 20
| |||
Form 4
| +19.99% | 1.39K |
$6.15 | -$7,841.25 | 8.33K |
May 17
| |||
Form 4
| +24.00% | 1.34K |
$6.48 | -$8,553.60 | 6.94K |
Apr 17
| |||
Form 4
| +33.76% | 1.41K |
$7.10 | -$8,875.00 | 5.6K |
Mar 17 - Mar 20
| |||
Form 4
| +40.85% | 1.21K |
$8.10 | -$11,745.00 | 4.19K |
Feb 17
| |||
Form 4
| +66.59% | 1.19K |
$8.70 | -$12,832.50 | 2.97K |
Jan 17 - Jan 18
| |||
Form 4
|
∞
| 1.78K |
$8.18 | -$7,198.40 | 1.78K |
Dec 22
| |||
Form 4
|
—
|
0
|
$9.35 | -$24,890.53 |
0
|
Nov 17 - Nov 21
| |||
Form 4
| -100.00% | -1.77K |
$9.44 | -$16,745.50 |
0
|
Nov 14
| |||
Form 4
|
∞
| 1.77K |
$11.48 | -$10,220.31 | 1.77K |
Oct 17
| |||
Form 4
|
—
|
0
|
$9.53 | -$25,381.59 |
0
|
Sep 17 - Sep 20
| |||
Form 4
|
—
|
0
|
$10.81 | -$345,509.22 |
0
|
Aug 17 - Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apellis Pharmaceuticals, Inc. (APLS) Snapshot price: $41.65
Chief Research Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$36.92 | -$461,500.00 | 68.3K |
Scheduled
|
Dec 1
| ||
Form 4
| -2.51% | -1.76K |
$43.01 | -$75,525.56 | 68.3K |
Sep 6
| |||
Form 4
| +15.17% | 9.17K |
$58.50 | -$41,827.50 | 69.64K |
Feb 21
| |||
Form 4
| -1.11% | -678.00 |
$51.21 | -$34,720.38 | 60.47K |
Feb 10
| |||
Form 4
| -0.88% | -542.00 |
$52.77 | -$28,601.34 | 61.15K |
Jan 27
| |||
Form 4
| -3.16% | -2.02K |
$52.05 | -$104,880.75 | 61.69K |
Jan 20
| |||
Form 4
| +54.90% | 22.58K |
—
|
—
| 63.71K |
Jan 12
| |||
Form 4
| -22.73% | -11.88K |
$43.00 | -$430,000.00 | 40.36K |
Apr 21 - May 27
| |||
Form 4
|
—
|
0
|
$36.97 | -$28,158.33 | 52.23K |
Apr 5
| |||
Form 4
|
—
|
0
|
$35.41 | -$151,058.73 | 52.23K |
Apr 4
| |||
Form 4
|
—
|
0
|
$34.45 | -$473,635.20 | 52.23K |
Apr 1
| |||
Form 4
| +1.40% | 720 |
$26.73 | $19,245.60 | 52.23K |
Feb 14
| |||
Form 4
| -3.13% | -1.67K |
$46.80 | -$77,968.80 | 51.51K |
Feb 11
| |||
Form 4
| -1.26% | -678.00 |
$31.84 | -$393,447.36 | 53.18K |
Feb 10
| |||
Form 4
|
—
|
0
|
$29.43 | -$311,500.00 | 53.86K |
Feb 8
| |||
Form 4
| -3.36% | -1.88K |
$38.51 | -$72,208.29 | 53.86K |
Jan 28 - Jan 31
| |||
Form 4
| +87.77% | 26.05K |
—
|
—
| 55.73K |
Jan 21
| |||
Form 4
| +11.33% | 3.02K |
$26.73 | $80,751.33 | 29.68K |
Jan 21
| |||
Form 4
| -11.36% | -3.42K |
$60.00 | -$205,020.00 | 26.65K |
Jun 10
| |||
Form 4
| -2.27% | -680.00 |
$47.72 | -$32,449.60 | 29.29K |
Feb 10
| |||
Form 4
| +45.52% | 9.38K |
—
|
—
| 29.97K |
Jan 28
| |||
Form 4
| +57.06% | 7.48K |
$26.73 | $199,993.86 | 20.59K |
Dec 8
| |||
Form 4
| +319.42% | 9.38K |
—
|
—
| 12.31K |
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
∞
| 2.94K |
$20.37 | $59,785.95 | 2.94K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||